<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK547961" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK547961/" /><meta name="ncbi_pagename" content="Lopinavir - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Lopinavir - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Lopinavir" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2017/09/01" /><meta name="citation_pmid" content="31643294" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK547961/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Lopinavir" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2017/09/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK547961/" /><meta name="description" content="Lopinavir is an antiretroviral protease inhibitor used in combination with ritonavir in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Lopinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and, rarely, clinically apparent, acute liver injury. In HBV or HCV coinfected patients, highly active antiretroviral therapy with lopinavir may result of an exacerbation of the underlying chronic hepatitis B or C." /><meta name="og:title" content="Lopinavir" /><meta name="og:type" content="book" /><meta name="og:description" content="Lopinavir is an antiretroviral protease inhibitor used in combination with ritonavir in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Lopinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and, rarely, clinically apparent, acute liver injury. In HBV or HCV coinfected patients, highly active antiretroviral therapy with lopinavir may result of an exacerbation of the underlying chronic hepatitis B or C." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK547961/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Lopinavir/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK547961/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B3AF80466A4B100000000064101E4.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK547961_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK547961_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Loperamide/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/LoratadineDesloratad/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK547961_"><span class="title" itemprop="name">Lopinavir</span></h1><p class="small">Last Update: <span itemprop="dateModified">September 1, 2017</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Lopinavir.OVERVIEW"><h2 id="_Lopinavir_OVERVIEW_">OVERVIEW</h2><div id="Lopinavir.Introduction"><h3>Introduction</h3><p>Lopinavir is an antiretroviral protease inhibitor used in combination with ritonavir in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Lopinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and, rarely, clinically apparent, acute liver injury. In HBV or HCV coinfected patients, highly active antiretroviral therapy with lopinavir may result of an exacerbation of the underlying chronic hepatitis B or C.</p></div><div id="Lopinavir.Background"><h3>Background</h3><p>Lopinavir (loe pin' a vir) is a peptidomimetic HIV protease inhibitor that acts by binding to the catalytic site of the HIV protease, thereby preventing the cleavage of viral polyprotein precursors into mature, functional proteins that are necessary for viral replication. Lopinavir is usually given in combination with low &#x0201c;booster&#x0201d; doses of ritonavir which improves the pharmacokinetics of lopinavir by slowing its hepatic metabolism. Lopinavir was approved for use in the United States in 2000 for the treatment of HIV infection in adults and children. Lopinavir in fixed combination with ritonavir is available as tablets of 100 mg/25 mg and 200 mg/50 mg and as an oral solution (80/20 mg per mL) for pediatric use generically and under the brand name Kaletra. The recommended dosage of lopinavir in adults is 800 mg daily in combination with 200 mg of ritonavir, either once daily or in two divided doses. Pediatric doses are based upon body weight or body surface area. Common side effects include gastrointestinal upset, nausea, diarrhea, fatigue, headache, and, with long term therapy, dyslipidemia and lipodystrophy.</p></div><div id="Lopinavir.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>Some degree of serum aminotransferase elevations occur in a high proportion of patients taking lopinavir containing antiretroviral regimens. Moderate-to-severe elevations in serum aminotransferase levels (&#x0003e;5 times the upper limit of normal) are found in 3% to 10% of patients, although rates may be higher in patients with HIV-HCV coinfection. These elevations are usually asymptomatic and self-limited and can resolve even with continuation of the medication. Clinically apparent liver disease due to lopinavir/ritonavir occurs, but is rare. The latency to onset of symptoms or jaundice is usually 1 to 8 weeks and the pattern of serum enzyme elevations varies from hepatocellular to cholestatic or mixed. The injury is usually self-limited; however, fatal cases have been reported. In addition, initiation of lopinavir/ritonavir based highly active antiretroviral therapy can lead to exacerbation of an underlying chronic hepatitis B or C in coinfected individuals, typically arising 2 to 12 months after starting therapy, and associated with a hepatocellular pattern of serum enzyme elevations and increases in serum levels of hepatitis B virus (HBV) DNA or hepatitis C virus (HCV) RNA. Lopinavir therapy has not been clearly linked to lactic acidosis and acute fatty liver that is reported in association with several nucleoside analogue reverse transcriptase inhibitors.</p><p>Likelihood score: D (possible, rare cause of clinically apparent liver injury).</p></div><div id="Lopinavir.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The cause of the clinical hepatotoxicity from lopinavir may be due to its metabolism by the liver, which is largely by the cytochrome P450 system (CYP3A4), which may result in production of a toxic intermediate. In patients with HBV or HCV coinfection, initiation of highly active antiretroviral therapy including lopinavir may be associated with flares of the underlying chronic hepatitis which are thought to be the result of reconstitution of the immune system, viral interactions or a direct effect of the drug on the hepatitis virus.</p></div><div id="Lopinavir.Outcome_and_Management"><h3>Outcome and Management</h3><p>The severity of liver injury ranges from mild enzyme elevations to acute liver failure. In typical cases, recovery occurs within 1 to 2 months of stopping lopinavir. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.rechallenge/">Rechallenge</a> may lead to recurrence and should be avoided. There does not appear to be cross reactivity to hepatic injury with other protease inhibitors or antiretroviral agents. The exacerbation of hepatitis B or C that can occur with lopinavir based antiretroviral therapies can be severe and lead to acute liver failure or progressive end stage liver disease. Patients with HCV or HBV coinfection should be monitored prospectively for viral and serum aminotransferase levels and appropriate therapy instituted if possible.</p><p>References to loprinavir are included with references to all the HIV protease inhibitors in the overview section of Protease Inhibitors (updated September 2017). Most of the HIV protease inhibitors in clinical use are proteinomimetic drugs and are structurally unrelated.</p><p>Drug Class: <a href="/books/n/livertox/AntiviralAgents/">Antiviral Agents</a>, Antiretroviral Agents</p><p>Other Drugs in the Subclass, <a href="/books/n/livertox/HIVProteaseInhibitor/">Protease Inhibitors</a>: <a href="/books/n/livertox/AmprenavirFosampren/">Amprenavir</a>, <a href="/books/n/livertox/Atazanavir/">Atazanavir</a>, <a href="/books/n/livertox/Darunavir/">Darunavir</a>, <a href="/books/n/livertox/AmprenavirFosampren/">Fosamprenavir</a>, <a href="/books/n/livertox/Indinavir/">Indinavir</a>, <a href="/books/n/livertox/Nelfinavir/">Nelfinavir</a>, <a href="/books/n/livertox/Ritonavir/">Ritonavir</a>, <a href="/books/n/livertox/Saquinavir/">Saquinavir</a>, <a href="/books/n/livertox/Tipranavir/">Tipranavir</a></p></div></div><div id="Lopinavir.CASE_REPORTS"><h2 id="_Lopinavir_CASE_REPORTS_">CASE REPORTS</h2><div id="Lopinavir.Case_1._Serum_aminotransferase"><h3>Case 1. Serum aminotransferase elevations during lopinavir/ritonavir therapy in a patient with HIV-HCV co-infection.</h3><p>[Modified from: Kottilil S, Polis MA, Kovacs JA. HIV Infection, hepatitis C infection, and HAART: hard clinical choices. JAMA 2004; 292:243-50. <a href="https://www.ncbi.nlm.nih.gov/pubmed/15249574" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A patient with HIV and HCV coinfection was found to have elevations in serum aminotransferase levels 3 months after starting an antiretroviral regimen of abacavir, didanosine, and lopinavir/ritonavir. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.aminotransferase/">Aminotransferase</a> levels had been near normal when therapy was started. He was asymptomatic and physical examination was normal, without fever, rash or jaundice. Laboratory tests showed <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> elevations of more than 5 times the upper limit of normal and at least five times baseline values (Table). All antiretroviral agents were stopped and ALT levels decreased. He was restarted on lamivudine, didanosine and lopinavir/ritonavir and serum enzymes remained unchanged. He tested positive for anti-HCV and HCV RNA levels were moderately high (780,000 IU/mL). A liver biopsy showed moderate necroinflammatory activity and bridging hepatic fibrosis. He was treated with peginterferon and ribavirin for 48 weeks in an attempt to eradicate the HCV infection, but serum aminotransferase and HCV RNA did not change. He was maintained on his four drug regimen for HIV infection and remained asymptomatic with CD4 counts above 300/<i>&#x003bc;</i>L and no opportunistic infections.</p><div id="Lopinavir.Key_Points1"><h4>Key Points</h4><div id="Lopinavir.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547961/table/Lopinavir.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Lopinavir.T1_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Medication:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Lopinavir/ritonavir</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Hepatocellular</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Severity:</td><td rowspan="1" colspan="1" style="vertical-align:top;">1+</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</td><td rowspan="1" colspan="1" style="vertical-align:top;">1 month</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</td><td rowspan="1" colspan="1" style="vertical-align:top;">4 weeks</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Didanosine, lamivudine, abacavir</td></tr></tbody></table></div></div></div><div id="Lopinavir.Laboratory_Values1"><h4>Laboratory Values</h4><div id="Lopinavir.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547961/table/Lopinavir.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Lopinavir.T2_lrgtbl__"><table><thead><tr><th id="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.aspartate-aminotransferase-ast-/">AST</a> (U/L)</th><th id="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P (U/L)</th><th id="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)</th><th id="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HCV RNA (IU/mL)</th></tr></thead><tbody><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Pre</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">43</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">158</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.6</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1 hd_h_Lopinavir.T2_1_1_1_2 hd_h_Lopinavir.T2_1_1_1_3 hd_h_Lopinavir.T2_1_1_1_4 hd_h_Lopinavir.T2_1_1_1_5 hd_h_Lopinavir.T2_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">Started abacavir, didanosine, and lopinavir/ritonavir</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">12 weeks</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">286</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">158</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.1</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1 hd_h_Lopinavir.T2_1_1_1_2 hd_h_Lopinavir.T2_1_1_1_3 hd_h_Lopinavir.T2_1_1_1_4 hd_h_Lopinavir.T2_1_1_1_5 hd_h_Lopinavir.T2_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">All antiretrovirals stopped</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">16 weeks</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">14 weeks</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">76</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">105</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.7</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1 hd_h_Lopinavir.T2_1_1_1_2 hd_h_Lopinavir.T2_1_1_1_3 hd_h_Lopinavir.T2_1_1_1_4 hd_h_Lopinavir.T2_1_1_1_5 hd_h_Lopinavir.T2_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">Restarted lamivudine, didanosine, and lopinavir/ritonavir</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">4 weeks</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">197</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">123</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.1</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">780,000</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">12 months</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">117</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">114</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.4</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">772,571</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1 hd_h_Lopinavir.T2_1_1_1_2 hd_h_Lopinavir.T2_1_1_1_3 hd_h_Lopinavir.T2_1_1_1_4 hd_h_Lopinavir.T2_1_1_1_5 hd_h_Lopinavir.T2_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">Started peginterferon alfa-2b and ribavirin (48 weeks)</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">13 months</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">54</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">122</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.9</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">14 months</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">34</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">91</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.5</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">887,876</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">15 months</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">21</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">116</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.2</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">513,209</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">2 years</td><td headers="hd_h_Lopinavir.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">107</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">104</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.7</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">179,950</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1 hd_h_Lopinavir.T2_1_1_1_2 hd_h_Lopinavir.T2_1_1_1_3 hd_h_Lopinavir.T2_1_1_1_4 hd_h_Lopinavir.T2_1_1_1_5 hd_h_Lopinavir.T2_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">Peginterferon and ribavirin stopped</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1 hd_h_Lopinavir.T2_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;">1 year later</td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">134</td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">111</td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.3</td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">226,200</td></tr><tr><td headers="hd_h_Lopinavir.T2_1_1_1_1 hd_h_Lopinavir.T2_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Lopinavir.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;42</b></td><td headers="hd_h_Lopinavir.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;116</b></td><td headers="hd_h_Lopinavir.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Lopinavir.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div></div><div id="Lopinavir.Comment1"><h4>Comment</h4><p>This patient had HIV-HCV coinfection and the chronic hepatitis C appeared to worsen when highly active antiretroviral therapy, which included lopinavir and low doses of ritonavir, was started. He did not, however, develop symptoms or jaundice. A liver biopsy revealed significant degrees of necroinflammatory activity and fibrosis, and he was treated with a 48 week course of peginterferon and ribavirin. While therapy of the hepatitis C led to transient improvements in serum aminotransferase levels, it had little effect on HCV RNA concentrations and no lasting effect on the disease activity. The worsening of hepatitis C with initiation of antiretroviral therapy has been attributed to reconstitution of the immune system. There is little evidence, however, that antiretroviral therapy leads to an increase in end stage liver disease or worse long term outcomes due to hepatitis C.</p></div></div><div id="Lopinavir.Case_2._Acute_cholestatic_hepa"><h3>Case 2. Acute cholestatic hepatitis due to lopinavir/ritonavir therapy.</h3><p>[Modified from: Zell SC. Clinical vignette in antiretroviral therapy: jaundice. J Int Assoc Physicians AIDS Care 2003; 2: 133-9. <a href="https://www.ncbi.nlm.nih.gov/pubmed/14986514" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 35 year old man with long standing HIV infection developed jaundice and itching 17 months after starting a regimen including lopinavir/ritonavir, stavudine and lamivudine. He had been treated successfully for mycobacterium avium intracellulare (MAI) infection, and follow up cultures were negative after a prolonged course of clarithromycin and ethambutol, which had been stopped several months previously. Physical examination showed jaundice, without fever, rash or signs of chronic liver disease. Blood tests showed elevations in serum bilirubin (total 12.6 mg/dL, direct 8.5 mg/dL), alkaline phosphatase (435 U/L) and <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> (200 U/L) (Table). Tests for hepatitis A, B and C were negative. A contrast CT showed no evidence of biliary obstruction. All antiretroviral agents were stopped, but serum alkaline phosphatase levels continued to rise. A liver biopsy showed no evidence of MAI infection or extrahepatic obstruction. After a week, his liver tests begin to improve and he was restarted on antiretroviral therapy using stavudine, lamivudine and nelfinavir. Eight weeks after initial presentation, his serum bilirubin and aminotransferase levels had fallen to normal.</p><div id="Lopinavir.Key_Points2"><h4>Key Points</h4><div id="Lopinavir.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547961/table/Lopinavir.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Lopinavir.T3_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Medication:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Lopinavir/ritonavir</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Cholestatic (R=1.5)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Severity:</td><td rowspan="1" colspan="1" style="vertical-align:top;">3+ (jaundice, hospitalization)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</td><td rowspan="1" colspan="1" style="vertical-align:top;">17 months</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</td><td rowspan="1" colspan="1" style="vertical-align:top;">2 months</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Stavudine, lamivudine; previously ethambutol and clarithromycin</td></tr></tbody></table></div></div></div><div id="Lopinavir.Laboratory_Values2"><h4>Laboratory Values</h4><div id="Lopinavir.T4" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547961/table/Lopinavir.T4/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Lopinavir.T4_lrgtbl__"><table><thead><tr><th id="hd_h_Lopinavir.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Lopinavir.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_Lopinavir.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> (U/L)</th><th id="hd_h_Lopinavir.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P (U/L)</th><th id="hd_h_Lopinavir.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)</th><th id="hd_h_Lopinavir.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Lopinavir.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">17 weeks</td><td headers="hd_h_Lopinavir.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Lopinavir.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">200</td><td headers="hd_h_Lopinavir.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">435</td><td headers="hd_h_Lopinavir.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">12.6</td><td headers="hd_h_Lopinavir.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Antiretroviral therapy stopped</td></tr><tr><td headers="hd_h_Lopinavir.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Lopinavir.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1 week</td><td headers="hd_h_Lopinavir.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Lopinavir.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">958</td><td headers="hd_h_Lopinavir.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Lopinavir.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Liver biopsy</td></tr><tr><td headers="hd_h_Lopinavir.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Lopinavir.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1.5 weeks</td><td headers="hd_h_Lopinavir.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">105</td><td headers="hd_h_Lopinavir.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">375</td><td headers="hd_h_Lopinavir.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">3.2</td><td headers="hd_h_Lopinavir.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Discharged</td></tr><tr><td headers="hd_h_Lopinavir.T4_1_1_1_1 hd_h_Lopinavir.T4_1_1_1_2 hd_h_Lopinavir.T4_1_1_1_3 hd_h_Lopinavir.T4_1_1_1_4 hd_h_Lopinavir.T4_1_1_1_5 hd_h_Lopinavir.T4_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">Restarted lamivudine, stavudine, and nelfinavir</td></tr><tr><td headers="hd_h_Lopinavir.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">19 weeks</td><td headers="hd_h_Lopinavir.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">8 weeks</td><td headers="hd_h_Lopinavir.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_Lopinavir.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">319</td><td headers="hd_h_Lopinavir.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.1</td><td headers="hd_h_Lopinavir.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Lopinavir.T4_1_1_1_1 hd_h_Lopinavir.T4_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Lopinavir.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;40</b></td><td headers="hd_h_Lopinavir.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;130</b></td><td headers="hd_h_Lopinavir.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Lopinavir.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div></div><div id="Lopinavir.Comment2"><h4>Comment</h4><p>A cholestatic hepatitis arose during antiretroviral therapy, the most likely cause being lopinavir/ritonavir, rather than stavudine and lamivudine which had been tolerated for several years and which was restarted without recurrence of the liver injury. The liver biopsy did not show steatosis and features of mitochondrial injury that would be typical of stavudine. With no other competing diagnosis, the likelihood that this case represented lopinavir/ritonavir induced liver injury is high.</p></div></div></div><div id="Lopinavir.PRODUCT_INFORMATION"><h2 id="_Lopinavir_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="Lopinavir.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Lopinavir &#x02013; Kaletra&#x000ae;</p><p><b>DRUG CLASS</b></p><p>Antiviral Agents</p><p><a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=Lopinavir" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMPLETE LABELING</a></p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="Lopinavir.CHEMICAL_FORMULA_AND_STRUCTURE"><h2 id="_Lopinavir_CHEMICAL_FORMULA_AND_STRUCTURE_">CHEMICAL FORMULA AND STRUCTURE</h2><div id="Lopinavir.T5" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547961/table/Lopinavir.T5/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Lopinavir.T5_lrgtbl__"><table><thead><tr><th id="hd_h_Lopinavir.T5_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Lopinavir.T5_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NUMBER</th><th id="hd_h_Lopinavir.T5_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Lopinavir.T5_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Lopinavir.T5_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Lopinavir</td><td headers="hd_h_Lopinavir.T5_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135051036" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">192725-17-0</a></td><td headers="hd_h_Lopinavir.T5_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C37-H48-N4-O5</td><td headers="hd_h_Lopinavir.T5_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK547961/bin/Lopinavir_Structure.jpg" alt="Lopinavir Chemical Structure" /></div></td></tr></tbody></table></div></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK547961</span><span class="label">PMID: <a href="/pubmed/31643294" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31643294</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Loperamide/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/LoratadineDesloratad/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK547961&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK547961/?report=reader">PubReader</a></li><li><a href="/books/NBK547961/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK547961" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK547961" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Lopinavir. [Updated 2017 Sep 1].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK547961/pdf/Bookshelf_NBK547961.pdf">PDF version of this page</a> (98K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=(Lopinavir/AE)+AND+Human%5BMH%5D+AND+(drug+induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI)+AND+(%221900/1/1%22%5BEDat%5D%3A%222999/12/31%22%5BEDat%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Lopinavir: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=Lopinavir" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Lopinavir: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pcsubstance&amp;IdsFromResult=4864398" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643624" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ritonavir</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ritonavir<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643351" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Saquinavir</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Saquinavir<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643253" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Atazanavir</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Atazanavir<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643326" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Darunavir</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Darunavir<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643985" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Indinavir</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Indinavir<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31643294" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31643294" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=604688980831bd46667131b3">Lopinavir - LiverTox</a><div class="ralinkpop offscreen_noflow">Lopinavir - LiverTox<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T15:27:05-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal104&amp;ncbi_phid=CE8B3AF80466A4B100000000064101E4&amp;ncbi_session=CE8B3AF804688981_1601SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK547961%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK547961&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK547961/&amp;ncbi_pagename=Lopinavir - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B3AF804688981_1601SID /projects/books/PBooks@9.2 portal104 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>